The document discusses appropriate antibiotic treatment for a patient with deep soft tissue and bone cultures growing methicillin-sensitive Staphylococcus aureus and Group B Streptococcus. It recommends an anti-staphylococcal and streptococcal antibiotic such as cephalexin. It also cautions monitoring vancomycin minimum inhibitory concentrations to watch for rising resistance and considers alternatives if the MIC is greater than 1μg/ml.